REGENXBIOvsThermo Fisher Scientific

RGNX and TMO stock compared: price, dividend, valuation and results, from SEC filings.

RGNX

REGENXBIO Inc.

$7.24

Value $479M

-1.09%
RGNX's page

TMO

Thermo Fisher Scientific Inc

$686.79

Value $255B

-0.66%
TMO's page

REGENXBIO (RGNX) has a market value of $479M and Thermo Fisher Scientific (TMO) $255B. Over the last year, with dividends, RGNX moved -37.1% and TMO +19.1%. Dividend yield: RGNX none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    RGNX$479M

    TMO$255B

    TMO is 533 times RGNX

  • Revenue, 12 months

    RGNX$154M

    TMO$47.4B

    TMO is 308 times RGNX

  • Net income, 12 months

    RGNX-$175M

    TMO$7.1B

  • Operating margin

    RGNX-95.7%

    TMO17.9%

    113.6 points apart

  • ROIC

    RGNX-115.2%

    TMO8.2%

    123.4 points apart

  • P/E

    RGNX–

    TMO36.1

  • Dividend yield

    RGNX0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    RGNX-77.3%

    TMO+8.6%

    85.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

RGNX-77.3%

TMO+8.6%

5010020222023202420252026
Returns by period
PeriodRGNXWith dividendsTMOWith dividends
1 year since November 14, 2025-37.1%Price -37.1%+19.1%Price +18.7%
3 years since November 17, 2023-62.9%-28.1% a yearPrice -62.9%+48.7%+14.1% a yearPrice +47.2%
5 years since November 16, 2021-77.3%-25.6% a yearPrice -77.3%+8.6%+1.7% a yearPrice +7.1%
10 years since November 17, 2016-67.8%-10.7% a yearPrice -67.8%+374.5%+16.8% a yearPrice +361.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

RGNXREGENXBIOTMOThermo Fisher Scientific

Valuation

RGNXTMO
Valuation
Price$7.24$686.79
Market value$479M$255B
Enterprise value (EV)–$290B
P/E–36.1
P/E, 5-year median–32.7
P/B3.24.7
EV/EBIT–34.3
Free cash flow yield–3.0%

Results and growth

RGNXTMO
Results and growth
Revenue, 12 months$154M$47.4B
Net income, 12 months-$175M$7.1B
Free cash flow, 12 months-$155M$7.6B
Earnings per share, 12 months-$3.21$18.96
Revenue growth, year on year104.5%3.9%
Revenue growth a year, past+2.0%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

RGNXTMO
Margins and returns on capital
Gross margin––
Operating margin-95.7%17.9%
Net margin-113.9%14.9%
ROIC-115.2%8.2%
ROE-173.5%13.4%

Balance sheet

RGNXTMO
Balance sheet
Cash$251M$6.1B
Total debt–$41.4B
Net debt / EBITDA–3.7
Interest cover-4.1×5.5×

Dividends and buybacks

RGNXTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: RGNX or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, REGENXBIO or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($255B) is about 532.9 times REGENXBIO ($479M), at today's prices.

How did RGNX and TMO stock do over the last 10 years?

Since November 17, 2016, RGNX's price moved -67.8% and TMO's +361.3%. With dividends: RGNX -67.8% (-10.7% a year), TMO +374.5% (+16.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, RGNX or TMO?

The dividend yield at today's price is none for REGENXBIO and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, REGENXBIO or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -113.9% for REGENXBIO and 14.9% for Thermo Fisher Scientific, and the operating margin -95.7% and 17.9%. Revenue was $154M and $47.4B.

Which is the better investment, REGENXBIO or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.